AI assistant
Sending…
WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2006
Mar 13, 2006
30339_dirs_2006-03-13_0ee2987e-9145-41f3-a1de-43e67c2c491a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: WEST PHARMACEUTICAL SERVICES INC ((WST))
CIK: 0000105770
Period of Report: 2006-02-24
Reporting Person: ELLERS STEVEN A (COO & President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2006-02-24 | Common Stock | A | 11104 | — | Acquired | 107286.8025 | Direct |
| 2006-02-24 | Common Stock | A | 5553.719 | $32.5850 | Acquired | 112840.5215 | Direct |
| 2006-02-24 | Common Stock | A | 3500 | — | Acquired | 116340.5215 | Direct |
| 2006-02-24 | Common Stock | A | 13.16 | $32.7800 | Acquired | 16708.2343 | Indirect |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2006-02-24 | Stock Option (Right to Buy) | $32.5850 | A | 32488 | Acquired | 2016-02-24 | Common Stock (32488.00) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 2805.7411 | Indirect |
Footnotes
F1: Bonus and incentive shares granted on 2/24/06.
F2: Additional amount of shares due to achieving above targeted amount for first performance period of 3/7/05 Performance Vested Restricted Share grant.
F3: Amount in error as the incorrect price was used to calculate the number of shares.
F4: Reflects additional shares purchased through dividend reinvestments based on most recent plan statement.
More from WEST PHARMACEUTICAL SERVICES INC
Board/Management Information
2026
Jun 1
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 11
Declaration of Voting Results & Voting Rights Announcements
2026
May 5
Major Shareholding Notification
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Interim / Quarterly Report
2026
Apr 23
Earnings Release
2026
Apr 23
Major Shareholding Notification
2026
Mar 27